BETHLEHEM, Pa., April 28 /PRNewswire/ -- Particle Sciences, Inc. today announced the appointment of Hector Garcia to the position of Director, Quality Assurance. Mr. Garcia will report to Dr. Robert Lee, VP, Pharmaceutical Development.
Mr. Garcia joins Particle Sciences following more than 30 years experience in pharmaceutical quality and operations management. Most recently, he served Wyeth as Senior Director of Quality Operations. Prior to that, Mr. Garcia held senior management positions at Baxter Healthcare, Schering Plough, and Chelsea Laboratories. His areas of expertise include clinical manufacturing operations, commercial quality operations, site management, and managing successful relationships with the FDA, MHRA, and third party customers internationally.
Dr. Lee comments, "Hector brings a wealth of experience to the Particle Sciences team and a high level of maturity to our QA infrastructure. His background fits perfectly with our continued focus on building a strong quality system to support or advanced product development capabilities. Particle Sciences routinely deals with formulation-challenged API's and nanotechnology based systems. Hector has deep experience with a variety of dosage forms as well as in clinical trial material manufacturing, another area Particle Sciences is expanding".
Particle Sciences is an integrated provider of drug development services. Particle Sciences focuses on emulsions, gels, particulates and drug/device combination products with additional specialized capabilities in topical and mucosal drug delivery. Through a full range of formulation, analytic, and manufacturing services, Particle Sciences provides pharmaceutical companies with a complete and seamless development solution that minimizes the time and risk between discovery and the clinic. The company was founded in 1991 and is headquartered in Bethlehem, Pennsylvania. For more information on Particle Sciences, visit www.particlesciences.com.
Contact: Maureen Cochran 610-861-4701 firstname.lastname@example.org
|SOURCE Particle Sciences, Inc.|
Copyright©2009 PR Newswire.
All rights reserved